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side effects were collected and a specialized physical examination was made by an 
ophtalmologist (including slit lamp examination) to diagnose all corneal deposits 
cases. Visual symptoms were particularly investigated. A multivariate regression was 
then used to identify independent predictive factors for corneal deposits occurrence.
Results: The ophtalmologist clinical examination revealed 111 cases of corneal 
deposits (64.9%). Fifty fi ve patients (32.1%) were symptomatic (blurred vision in 
38 patients (22.2%) and decrease in visual acuity in 17 patients (9.9%)). All theses 
patients had corneal deposits.
On multivariate regression, only a cumulative dosage ≥100 g (p=0.016) and a 
treatment duration ≥12 months (p=0.026) were found to be independent predictors 
of corneal deposits with a cumulatif effect.
Conclusion: Corneal deposits are frequent side effects of amiodarone but are 
mostly asymptomatic. Independent predictors are cumulative dosage ≥100 g and 
treatment duration ≥12 months. 
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The safety and effi cacy for the Smarttouch Catheter in the treatment of 
symptomatic paroxysmal atrial fi brillation (the experience of the Brussels 
heart center about 100 patients) 
Hanane Benhalla (1), Camélia Sorea (2), Luc Deroy (2), Marc Castadot (2) 
(1) CHU Ibn Rochd, cardiologie, Casablanca, Maroc – (2) Brussels Heart 
Center, Bruxelles, Belgique
Introduction: The catheter, combined with 3D mapping and navigation software, 
gives physicians a real-time, objective measure of tip-to-tissue contact force during 
the catheter ablation procedure. The device is currently under investigation.
Description of the study: This is a retrospective study wich included 100 patients 
suffering from symptomatic paroxysmal atrial fi brillation (PAF) 
We studied as a primary endpoints the Effectiveness and safety during 6 months 
of ablation.
Our inclusion criteria were:
•  Failure with at least one antiarrhythmic drug shown by repeated atrial fi brillation 
episodes
• 18 years of age or older
• Exclusion Criteria including:
• Females who are pregnant or breast feeding 
Results:
Non smarttouch
(n=50)
Smartouch
(n=49)
P
Gender
Male 72% 57.1%
NS
Type de FA 
PAF
NPAF
72%
28%
69.4%
30.6%
NS
AF Duration
Mean (sd) days 43.1 (53.89) 41.10 (51.17) 
NS
Previous PVI 14% 16.3% NS
Previous Flutter Ablation 14% 20.4% NS
Procedure duration
Mean (sd) min 201.1 195.43 NS
Complications 10% 12.2 NS
Scopy duration
Mean (sd) min 45.36 28.18
<0.001
Sinus Rythm after 
procedure one month
86% 98% 0.029
Recidive at 6 months 36% 21.7% NS
Conclusion: We concluded that ablation of atrial fi brillation using this new 
device (the smarttouch cathter) is realy safe as a procedure,and reduce signifi cantly 
the scopy duration with a good result to have a sinus rythm at one months. However 
more studies are needed to confi rm our results.
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The substrate of atrial fi brillation associated with heart failure is characterized by 
a reduced atrial excitability despite normal electrical properties of atrial myocytes
Vincent Algalarrondo (1), Nathalie Mougenot (2), Adeline Jacquet (2), Catherine 
Eichel (3), Elise Balse (3), Alain Coulombe (3), Stéphane Hatem (3) 
(1) Unité Inserm U 769, signalisation et physiopathologie cardiaque, service de 
cardiologie, Hôpital A. Béclère, Clamart, France – (2) UPMC, Institut fédératif 
de recherche cœur muscle vaisseaux, Inserm, Plateforme d’expérimentation cœur 
muscles et vaisseaux, Paris, France – (3) Inserm UMRS 956, UPMC, Paris, France
Background: Heart failure (HF) is major risk factor of atrial fi brillation (AF) 
by favoring atrial remodeling. However, the nature of the arrhythmogenic substrate 
in this clinical setting is yet not completely understood.
Methods: HF rats were studied two months after ligation of the left coronary 
artery (male Wistar rats HF: n=27 vs sham: n=20). After cardiac echo and surface 
ECG, transient AF was induced using trans-esophageal burst in anesthetized rats. 
Cellular action potentials (AP) were recorded in intact atrial trabeculae using the 
classical microelectrode technique. Ionic currents were recorded by whole-cell patch 
clamp in freshly isolated atrial myocytes.
Results: HF rats had increased end diastolic LV diameter, low LV ejection fraction 
and marked atrial dilation (LA area: 34±9 vs 20±4 mm2; p<0.0001). On surface ECG, 
P wave, QRS complex and QTc interval were prolonged in HF. The episode of induced 
AF was longer in HF than sham (26±56 vs 9±9 sec; p=0.003). Duration of AF episode 
correlated with LA surface, end diastolic LV diameter and LV ejection fraction. In HF, 
atrial AP had lower resting potential (Er: -68±5 vs -70±5mV; p<0.0001) and a marked 
reduction of both dV/dtmax and AP amplitude (dV/dtmax: 110±48 vs 138±39V/s; 
p<0.0001; AP amplitude: 69±13 vs 79±7 mV; p<0.0001). AP durations measured at 
5, 25, and 50% of the repolarisation were shorter in HF than sham but not APD75 and 
APD90. Duration of AF episode was negatively correlated with dV/dtmax (R=-0.8; 
p=0.005) and AP amplitude (R=-0.7; p=0.01). Finally, current densities of the whole 
potassium currents and the sodium current did not differ between HF and sham.
Conclusion: The arrhythmogenic substrate of AF due to HF is characterized 
by reduced myocardial excitability. The lack of changes of the main ionic currents 
involved in the resting potential and rapid depolarization of atrial myocytes points 
to the role of tissue factor such as myofi broblast proliferation as a mechanism of 
depressed excitability during HF.
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What are the predictors of corneal deposits occurrence when taking 
amiodarone ?
Fatma Ben Amor, Majed Hassine, Mejdi Ben Messaoud, Anis Elloumi, Khelif 
Mehdi, Zohra Dridi, Fethi Betbout, Habib Gamra
CHU Fattouma Bourguiba Monastir Tunisia, cardiologie A du Professeur Habib 
Gamra, Monastir, Tunisie
Background: Amiodarone is characterized by a high tissular fi xation much more 
important than plasmatic concentration. The cornea is an elective site for accretion, 
and coreal deposits are the most frequent side effects of amiodarone.
Objective: To identify corneal deposits predictive factors among patients taking 
amiodarone.
Methods: Between May 2010 and September 2011, 171 patients taking amiodarone 
for more than 6 months were prospectively included in the Amiotox registry. All 
© Elsevier Masson SAS. All rights reserved.
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Comparison of cryotherapy and radiofrequency ablation in paroxysmal 
atrial fi brillation: intraoperative fi ndings and complications
Albin Behaghel, Raphael Martins, Jean-Claude Daubert, Christophe Leclercq, 
Philippe Mabo, Dominique Pavin
CHU Rennes, cardiologie, Rennes, France
Backgrounds: Isolation of the pulmonary veins (PVs) is a curative treatment of 
paroxysmal atrial fi brillation (AF). The purpose of this study was to comparate two 
methods of PVs isolation in effi cacy and safety.
Methods: We restropectively studied 198 patients (age 59±9, ejection fraction 
0.6±0.06, left atrial size 40±5 mm) with paroxysmal AF treated with PVs isolation at 
Rennes between 2007 and 2011. 114 patients treated with cryoballoon and 84 patients 
treated with radiofrequency (RF).
Results: Procedure duration was 173±40 minutes and fl uoroscopy duration was 
49±16 minutes in the cryoballoon group versus respectively 267±64 minutes and 
63±20 minutes in the RF group. 438 (96%) of 456 PVs targeted with cryoballoon were 
isolated versus 307 (91%) of 336 PVs targeted with RF. 3 major complications (2%) 
(1 tamponade, 1 transient ischemic attack, 1 tearing of the foramen ovale) occured 
in cryoballoon group versus 2 (2%) (1 tamponade, 1 wound of the left atrium) in RF 
group. 24 minor complications (21%) (6% groin complications, 10% transient phrenic 
nerve paralysis, 4% pericardial effusion) occured in cryoballoon group versus 19 
(22%) (7% groin complications, 10% pericardial effusion, 1% sepsis) in RF group.
Conclusions: In paroxysmal AF feasibility and complications rate of two methods 
of PVs isolation appears similar, the data concerning the long-term outcome are 
ongoing and could help determine the superiority of one or the other techniques. 
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Diagnosis of unknown atrial fi brillation among 65+ years patients in general 
practice using a specifi c AF symptoms questionnaire (PROFIL FA) 
Ziad Khoueiry (1), François Roubille (1), Philippe Lambert (2), Cherif Heroum (1), 
Antoine Avignon (1), Didier Caumette (3), Claude Jeandel (1), Jean-Marc Davy (1) 
(1) CHU de Montpellier, Montpellier cedex 05, France – (2) Médecin généraliste, 
Mèze, France – (3) Boehringer-Ingelheim, Paris, France
Opportunistic screening of atrial fi brillation (AF) using pulse-taking in all patients 
over 65 years was recently recommended (ESC 2012 AF guidelines). Indeed unknown 
AF represents up to 20% of ischemic stroke associated with AF. If AF could be silent, 
detected primarily by the arterial pulse and mainly by several ECG techniques, AF can 
also be simply unknown because the symptoms exist but are unrecognized.
Purpose of the study: Systematic search of a possible AF, either paroxysmal, 
persistent, or permanent, in all patients over 65 years seen in general practice.
Method: For one week, all patients over 65 years were subjected to a questionnaire 
looking for paroxysmal and unexplained episodes of palpitations, weakness, chest 
pain, or shortness of breath. If any symptom was found, an advice was requested 
from a cardiology specialist.
Results: a total of 446 patients over 65 years were seen during a week by 38 
GPs (range 2-22, mean 11.7). The average age was 76.8 years, 63% were male, 60% 
were hypertensive, 22.8% diabetic, and 14.1% had a previous stroke. For 72 patients, 
AF was already known; their average age was 81.8 years, 67% were male, 78% were 
hypertensive, 37.5% diabetic, and 43% had a previous stroke; no symptom was present 
in 16 of them (22%). AF was suspected in 67 other patients, with either palpitations 
(n=19), weakness (n=22), chest pain (n=11), or shortness of breath (n=24). The average 
age was 77.7 years, 55% were male, 59% were hypertensive, 20.8% diabetic, and 
17.9% had a previous stroke. A cardiologist consultation was proposed, and AF was 
confi rmed in 6 patients (9%) who received appropriate treatment.
Conclusion: The use of a specifi c AF questionnaire is likely to detect AF in at 
risk patients seen in general practice. Improvement of the care pathways in AF can 
be expected.
215
Acute rate of transmural lesions induced by the Epicor system® during 
peri-operative left atrial ablation for atrial fi brillation
Amine Bennadji, Bertrand Marcheix, Christophe Cron, Duparc Alexandre, Pierre 
Mondoly, Marc Delay, Anne Rollin, Yves Glock, Phillipe Maury
CHU Rangueil, cardiologie, Toulouse, France
Introduction: The Epicor system® is based on high intensity focused ultrasound 
(HIFU) energy used for creating a wide circumferential linear left atrial lesion encircling 
both left atrial posterior wall and pulmonary veins (box lesion) and provides long-term 
cure in patients with atrial fi brillation undergoing heart surgery. Whether if acute 
complete disconnection of the box lesion is achieved by application of HIFU is unknown.
Methods: bipolar pacing and detection into the box lesion was studied in 9 pts (5 
men, 77±18 yo) undergoing heart surgery (5 aortic valve replacement, 3 mitral valve 
repair or replacement and one coronary by-pass) using bipolar electrophysiological 
catheter and a real time telemetry (Medtronic CareLink® programmer), just after 
completion of the ablation process on the beating heart prior to initiation of extracor-
poreal circulation. Sinus rhythm was present or obtained using internal cardioversion 
in each before the ablation process.
Results: Entrance block was absent in 7 (1 to 1 conduction from sinus rhythm 
inside the box lesion), undetermined in one and present in one (dissociated slow local 
rhythm). Exit block was lacking in 6 (capture of the cardiac rate by pacing inside the 
box lesion) and present in 3 (dissociated sinus rhythm from the paced area).
Conclusion: Acute complete block of the Epicor® HIFU induced box lesion 
is lacking in the vast majority of pts despite completion of the energy deliverance 
according to the automated ablation process. Whether block later happens, or whether 
supplementary applications would increase the electrophysiological and clinical 
success rate is unknown.
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Safety and long-term effi cacy of surgical ablation of atrial fi brillation. A 
single center experience
Sylvain Ropars (1), Eric Bezon (2), Philippe Castellant (3), Marjaneh Fatemi (3), 
Martine Gilard (3), Jacques Mansourati (1) 
(1) CHRU Brest, département de cardiologie, Brest cedex, France – (2) CHRU 
Brest, service de chirurgie cardiothoracique et vasculaire, Brest, France – (3) 
CHU Brest, département de cardiologie, Brest cedex, France
Surgical ablation of atrial fi brillation (AF) is proposed in pts undergoing cardiac 
surgery in order to prevent recurrences. The aim of our study was to evaluate the 
safety and long-term effectiveness of this procedure in a single center experience.
Methods: We studied retrospectively the charts of 144 pts who underwent surgery. 
Ablation (Cox Maze IV type) was performed in 73 of these pts (66.7±10 years). We 
compared perioperative complications and outcome in pts who underwent ablation 
(Ab+) or not (Ab-). 
Results: Cryoablation was used in 60.3% and RF ablation in 39.7% of pts. 
Perioperative mortality was 5.5%. Complications were similar in both groups. Sinus 
rhythm (SR) persisted in 46.8% and 31.4% of pts respectively at 1 year and at the 
end of FU period (4.4±3.5 years). There was no benefi cial effect of ablation on stroke 
(5.8% vs 4.5%, p=0.85) or survival. Ab+ had a lower long-term prevalence of heart 
failure (16.2% vs 43.9%, p<0.001). Independent predictors of failure of ablation were 
an atrial wave amplitude during AF in V1 <0.105 mV (OR=9.8, [2.02-47.27] p=0.04) 
and less signifi cantly a Euroscore >6% (OR=0.35, [0.12-1.03]; p=0.06). Associated 
factors were a left atrial diameter>55 mm, obesity, smoking, and a rheumatic etiology 
of valvular disease.
Conclusion: Surgical ablation of AF using the Cox Maze IV scheme seems to 
be safe and effi cient with a signifi cant clinical benefi t. Pts should be however selected 
before ablation.
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Clinical and procedural features associated with high risk of multiple 
procedures to achieve paroxysmal atrial fi brillation ablation 
Sana Amraoui (1), Nicolas Derval (2), Adlane Zemmoura (2), Frederic Sacher (2), 
Arnaud Denis (2), Mélèze Hocini (2), Pierre Jais (2), Michel Haissaguerre (2) 
(1) Haut Lévêque, Pessac, France – (2) Service du Pr Haissaguerre, Pessac, France
Introduction: Catheter ablation of paroxysmal AF has proven effi cacy and safety. 
However, more than 20% of patients require more than one procedure to achieve 
clinical success. We aimed to identify groups of patients associated with higher risk 
of AF recurrence after PAF ablation.
Methods: All patients referred for catheter ablation of PAF (<7 days) in our 
institution were included in the study. All patients had lasso-guided PVI, additional 
LA substrate ablation (complex fractionated electrogram (CFE), linear ablation) was 
performed if spontaneous or induced AF was sustained after PVI. Follow-up visit 
were performed at 3, 6 and 12 months with clinical evaluation, TTE, 24 hours holter 
monitoring. Recurrence was defi ned by more than 30sec of documented AF or typical 
symptoms of palpitation. We used uni- and multivariable models to identify predictors 
of AF recurrence over 12 months follow-up.
Results: A total of 338 Pts (55±11.2 yrs, 25.2% females) underwent a fi rst 
ablation for PAF between 2004 and 2010. Median longest reported AF episode was 12 
hours, range 1 to 168h. After 12±4.5 mo, 77.2% of pts were free of AF after a mean of 
1.5±0.8 procedures. After single procedure, criteria associated with more recurrence 
were: female gender (p=0.03), hypertension (p=0.01), longest episode ≥20h (p=0.10) 
(univariable model). Patients with longest episode ≤24h had more chance to achieve 
success after 1 procedure (0R=1.9; CI [1.02-3.78]). 
Conclusions: In PAF ablation longest episode of AF ≥20h, hypertension and 
female gender are associated with higher risk of AF recurrence.
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Left atrial parameters assessed by echography as predictors of Silent AF 
episodes during the acute phase of myocardial infarction 
Karim Stamboul (1), A. Gudjoncik (1), Luc Lorgis (1), Jean Claude Beer (1), 
Claude Touzery (1), Marianne Zeller (2), Yves Cottin (1) 
(1) Inserm UMR 866, LPPCM, Dijon cedex, France – (2) Inserm UMR866, 
LPPCM, Dijon, France
Atrial Fibrillation (AF) complicating an acute myocardial infarction (AMI) is 
common. Silent AF has also been suggested to be common in AMI. Its true incidence 
and characteristics in the current clinical daily practice remains unknown. The 
aims of our study were to assess silent AF incidence and determine its predictive 
factors, especially regarding left atrium parameters.
581 consecutive AMI were prospectively analyzed by Continuous ECG Scope 
Monitoring (CSM) for 48H after hospital admission. Left Atrial (LA) dimensions 
and Left Ventricular Ejection Fraction (LVEF) were determined on admission by 
echocardiography for each patient. We analyzed the study population into 3 groups: 
No AF, silent AF and symptomatic AF: Seventy-six (13.1%) patients had silent AF 
on CSM after MI. Compared with No AF group, patients of the silent AF group 
were markedly older (80(69-85) vs 62(53-74); p<0.001), more frequently women 
(34(45%) vs 131(27%); p=0.006), had more often hypertension (58(76%) vs 252(52%); 
p<0.001). They also had impaired LVEF (46% (13) vs 54% (11); p<0.001). Heart 
failure episodes during the acute phase after myocardial infarction were more frequent 
in silent AF group (42%) and in symptomatic AF group (53%) than in noAF group 
(21%), with p<0.001.After adjusting for confounding variables by multivariate analysis, 
indexed left atrial diameter (OR (95%): 2.37 (1.31-4.25) was the most powerful factor 
associated with development of silent AF after AMI. By ROC curve analysis, a LAVI 
of 26.88 mL/m2 was identifi ed as the best level predicting silent AF occurrence after 
AMI. Moreover, they had signifi cant LA enlargement based on left atrial volume 
indexed (LAVI) (36.12(23.06-45.77) vs 26.95(19.72-35.73) mL/m2; p=0.002). In this 
prospective study, CSM showed that silent AF in AMI is very common (16.4%), and 
is mostly underdiagnosed by classical discontinued serial ECG monitoring. LAVI 
should be evaluated on admission to predict silent AF occurrence and thereby the 
prognosis of patients after AMI.
Table – Abstract 254 – Recurrence after 1 procedure of PAF ablation : Odds Ratio
Univariable (95% CI) Multivariable (95% CI)
Longest AF episode >24h 1.4 (1.1 to 2.1) p=0.10 1.4 (0.9 to 2.3) p=0.14
HTA 1.8 (1.8 to 2.8) p=0.01 1.9 (1.2 to 3.1) p=0.01
Female gender 1.7 (1.1 to 2.8) p=0.03 1.7 (1.1 to 3.0) p=0.04
CHADS Socre ≥2 1.7 (0.8 to 3.6) p=0.13 – 
LA Size 1.0 (0.9 to 1.1) p=0.20 – 
LA substrate Modifi cation 0.8 (0.5 to 1.3) p=0.38 – 
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Clinical long term follow-up of 200 patients treated by ablation for drug 
refractory atrial fi brillation 
Segolene Rouffi ac (1), Bénédicte Godin Gardea (2), Fanny Bouchinet (2), Kévin 
Gardey (2), Arnaud Savoure (2), Frédéric Anselme (2) 
(1) CHU Charles Nicolle, Rouen, France – (2) CHU Charles Nicolle, Cardiologie, 
Rouen, France
Atrial fi brillation (AF) is the most common cardiac arrhythmia and is responsible 
for disabling symptoms in young patients. Drug-refractory AF is now frequently treated 
by catheter ablation, in order to obtain complete and sustained pulmonary vein isolation 
(PVI). This study aims to investigate effi ciency and safety of radiofrequency (RF) and 
cryoballoon ablation for paroxysmal and persistant AF in our center.
Our study was a retrospective cohort of 200 consecutive patients (pts) (age 57±10 
years), with drug-refractory, symptomatic paroxysmal (71%) or persistant AF. They 
underwent a fi rst AF ablation procedure between January 2007 and August 2010. 
Radiofrequency was used in 121 pts, suffering from persistant AF (48%). Extra-
venous ablation was performed in 27.5% and cavotricuspid isthmus in 21.5% of those 
ablation procedures. Cryoballoon PVI was performed in 79 pts, for paroxysmal AF 
in 87%. 
After 2 years of follow up, 39% of patients were in stable sinus rhythm after 
a single procedure (35% after radiofrequency and 44% after cryoballoon ablation). 
Radiofrequency redo procedures were performed in 49% pts after radiofrequency 
and 46% after cryoballoon ablation, with a mean of respectively 1.7±0.8 and 1.6±0.8 
ablation procedures per patient. After those redo procedures, 83.5% of patients were 
free from AF (respectively, 87% and 80%). At fi nal follow up (mean 34±14 months), 
87.5% patients were asymptomatic.
Major complications rate was 7%. We found no signifi cant difference between 
persistant and paroxysmal AF ablation results or between radiofrequency and cryoballoon 
AF ablation results.
This observational single centre study confi rms that ablation procedure is an 
effi cient adjuvant treatment for paroxysmal or persistant AF, with a reasonable 
complication rate.
